Thermo Fisher says it supported over 250 coronavirus-related programs in 2020, generating “well over $6 billion” in COVID-19 response revenue. Speaking at the JP Morgan Healthcare Conference, held virtually for the first time in its nearly 40 year history, Thermo Fisher Scientific CEO Marc Casper described 2020 as the “best year yet” for his firm, representing an “extraordinary performance in the most challenging of times.” The multinational offers a broad spectrum of biopharma services, all of which saw a surge…